News

The Cardinal Health Foundation today announced that, for the third consecutive year, it has awarded more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.

In a new study of four adenovirus vectors, researchers from the Wistar Institute show that a reportedly rare human adenovirus, called AdHu26, is not so rare, after all, and would thus be unlikely to be optimal as a vaccine carrier for mass vaccination.

Two researchers from the CDC report on the emerging issue of Clostridium difficile transmission via food in the community setting.  

The Association for the Advancement of Medical Instrumentation (AAMI) announces that the Industrial Ethylene Oxide Sterilization for Medical Devices Workshop, a three-day, highly interactive advanced workshop, will be held October 4-6, 2010 at the Westin Peachtree Plaza in Atlanta.

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing.

A new study by researchers from UCLA and Harvard University has found disparities among children suffering from repeated ear infections.

On Aug. 5, 2010, CDC's Advisory Committee on Immunization Practices (ACIP) met to discuss recommendations for use in the United States of seasonal influenza trivalent inactivated vaccine (TIV) [Afluria] manufactured by CSL Limited during 2010-11.

Adding a direct acting antiviral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the online edition of the journal The Lancet.